Trials by Primary Investigator: Slingluff Craig, L
Your search found 3 trials
Health System, Human Immune Therapy Center, seeks participants with melanoma for a research study.
The purpose of this study is to find out what effects drugs CCI-779 and bevacizumab have on participants and melanoma. CCI-779 is an expe...
Category:
Dermatology/Plastic Surgery
,
Cancer (Oncology)
Department:
Surgery
Primary Investigator:
Slingluff Craig, L
Health System, Human Immune Therapy Center, seeks participants with melanoma for a research study.
The purpose of this study is to find out what effects drugs CCI-779 and bevacizumab have on participants and melanoma. CCI-779 is an expe...
Category:
,
Dermatology/Plastic Surgery
,
Cancer (Oncology)
Department:
Surgery
Primary Investigator:
Slingluff Craig, L
UVa Health System, Human Immune Therapy Center, seeks adults 18 years or older with a diagnosis of subcutaneous or cutaneous Stage IIIB- IV metastatic melanoma for research study.
The purpose of the study is to determine the safety of ad...